| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 09/07/2007 | WO2007100066A1 17β HSD type 5 INHIBITOR |
| 09/07/2007 | WO2007099852A1 Method of testing sensitivity of solid cancer against tyrosine kinase inhibitor and test kit therefor |
| 09/07/2007 | WO2007099082A1 Novel method for the preparation of stavudine polymorphic form i and form ii |
| 09/07/2007 | WO2007029156A3 Isoindoledione derivatives as adrenergic receptor antagonists |
| 09/07/2007 | WO2007011760A3 Inhibitors of mitotic kinesin |
| 09/07/2007 | WO2006110476A3 Cytotoxic compounds and conjugates comprising duocarmycins with cleavable substrates |
| 09/07/2007 | CA2644809A1 17 .beta. hsd type 5 inhibitor |
| 09/07/2007 | CA2644069A1 Therapeutic piperazines as pde4 inhibitors |
| 09/07/2007 | CA2643044A1 Cinnoline and quinazoline derivates as phosphodiesterase 10 inhibitors |
| 09/07/2007 | CA2640754A1 Pyrazole derivatives as sigma receptors antagonists |
| 09/06/2007 | US20070208182 Zwitterionic Non-Linear Optophores And Devices Incorporating Same |
| 09/06/2007 | US20070208176 Biphenyl derivatives |
| 09/06/2007 | US20070208172 Process for Preparing Cephalosporin Intermediates Using Alpha-Iodo-1-Azetidineacetic Acid Esters and Trialkylphosphites |
| 09/06/2007 | US20070208166 Tao Kinase Modulators And Method Of Use |
| 09/06/2007 | US20070208049 e.g. 1-(2,6-Difluorobenzyl)-5-(3-Mehthoxyphenyl)-6-Methyl-3-[N-Methyl -N -(2-Pyridylethyl)Aminoethyl]Uracil; anticarcinoganic agent; prostate cancer, benign prostatic hypertrophy, breast cancer and endometriosis |
| 09/06/2007 | US20070208048 New Aryl Imidazoles and Related Compounds as C5a Receptor Modulators |
| 09/06/2007 | US20070208046 such as 4-benzyloxy-1-{4-[2-(dimethylamino)ethoxy]phenyl}-1H-pyridin-2-one, that as antagonists to melanin concentrating hormone receptors, used for treating cardiovascular, nervous system, metabolic, reproductive system, respiratory system and gatrointestinal disorders |
| 09/06/2007 | US20070208044 Compounds and therapeutical use thereof |
| 09/06/2007 | US20070208036 Arylalkanes, arylalkenes and aryl-azaalkanes, pharmaceutical compositions containing these compounds and processes for preparing them |
| 09/06/2007 | US20070208034 4,6-disubstituted pyrimidines and their use as protein kinase inhibitors |
| 09/06/2007 | US20070208033 Amine compound and use thereof |
| 09/06/2007 | US20070208024 (3-Fluoro-4'-methanesulfonyl-biphenyl-4-yl)-[2-(S)-(2-(R)-methyl-pyrrolidin-1-ylmethyl)-pyrrolidin-1-yl]-methanone; treatment of obesity, cognitive deficiencies, narcolepsy, and other histamine H3 receptor-related diseases |
| 09/06/2007 | US20070208019 Vasculostatic agents and methods of use thereof |
| 09/06/2007 | US20070208008 Substituted sulfonamides and ureas useful for inhibiting kinase activity |
| 09/06/2007 | US20070208007 Amine-Based Compound and Use Thereof |
| 09/06/2007 | US20070208005 Tetrahydrobenzazepines as antagonists and/or reverse agonists of the histamine h3 receptor |
| 09/06/2007 | US20070207991 Substituted N-aryl Heterocycles, Process For Their Preparation and Their Use As Medicaments |
| 09/05/2007 | EP1829873A1 Pyrrazole derivatives as sigma receptors antagonists |
| 09/05/2007 | EP1829865A2 Chemical compounds |
| 09/05/2007 | EP1828172A1 Pyrrole derivatives having crth2 receptor antagonist activity |
| 09/05/2007 | EP1828171A2 Heterocycle derivatives as histone deacetylase (hdac) inhibitors |
| 09/05/2007 | EP1828169A2 Urea inhibitors of map kinases |
| 09/05/2007 | EP1828167A2 Acrylamide derivatives as antibiotic agents |
| 09/05/2007 | EP1828148A1 Triazole substituted aminobenzophenone compounds |
| 09/05/2007 | EP1828146A1 Substituted n-heterocyclic compounds and their use as dopamine d3 receptor ligands |
| 09/05/2007 | EP1828144A2 Integrin antagonists useful as anticancer agents |
| 09/05/2007 | EP1828140A1 5-aminopyrazole derivatives as pesticidal compounds |
| 09/05/2007 | EP1828135A2 Compounds and compositions as modulators of steroidal receptors and calcium channel activities |
| 09/05/2007 | EP1828127A2 INSECTICIDAL BIS(SUBSTITUTED PHENYL)-1-äÝ4-(SATURATED HETEROCYCLYL-SUBSTITUTED)PHENYLMETHYL¨-(4-PIPERIDYL)üMETHANE DERIVATIVES |
| 09/05/2007 | EP1828125A1 Arylpiperazine derivatives and their use as ligangs selective of the dopamine d3 receptor |
| 09/05/2007 | EP1828123A1 Indolinones and their use as antiproliferative agents |
| 09/05/2007 | EP1828092A1 Process and intermediate compounds useful in the preparation of statins |
| 09/05/2007 | EP1730116B1 4-carbox pyrazole derivates useful as anti-viral agents |
| 09/05/2007 | EP1618094B1 Substituted heteroaryls as inhibitors of protein tyrosine phosphatases |
| 09/05/2007 | EP1474419B1 Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes |
| 09/05/2007 | EP1441724B1 Methods of increasing endogenous testosterone levels |
| 09/05/2007 | EP1373233B1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 09/05/2007 | CN101031563A Benzimidazole derivatives, composition containing thereof and its preparation and application |
| 09/05/2007 | CN101031558A HIV inhibiting 5-heterocyclyl pyrimidines |
| 09/05/2007 | CN101031550A HIV inhibiting 5-carbo- or heterocyclic substituted pyrimidines |
| 09/05/2007 | CN101031545A Isoindoline compounds and methods of their use |
| 09/05/2007 | CN101031539A Substituted arylalkanoic acid derivatives and use thereof |
| 09/05/2007 | CN101029042A Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 09/05/2007 | CN101029022A Process for the preparation of 4-phenoxy quinoline derivatives |
| 09/04/2007 | US7265228 N-(alpha-methylolbenzyl)1-(aminoethyl)- or 1-(aminocarbonyl)-2-aryl(especially phenyl or benzodioxanyl)-2-hydroxyethylamine intermediates for enantiomeric synthesis of amino ceramide-like compounds |
| 09/04/2007 | US7265226 Interact with opoid receptors; decreasing metabolic rates of the phenolic piperidines by amidation, imidation, or forming a formamide, a hydroxyamidine or a thioamide; analgesics, anticonvulsants, antitussive agents; diarrhea, drug addiction |
| 09/04/2007 | US7265152 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis C viral infections and associated diseases |
| 09/04/2007 | US7265146 Administering small molecule compounds, especially acids or esters, that inhibit the interaction between alpha 4 integrins and ligands MAdCAM and/or VCAM for treatment of chronic inflammatory diseases such as arthritis, asthma, multiple sclerosis, Chrohn's disease, ulcerative colitis, and hepatitis C |
| 09/04/2007 | US7265133 Biphenylylaminocarbonyl-amino- or -oxypiperidine derivatives, e.g., biphenyl-2-ylcarbamic acid 1-[2-({4-[(4-hydroxybenzylamino)methyl]benzoyl}methylamino)ethyl]piperidin-4-yl ester; treating bronchodilation and COPD |
| 09/04/2007 | US7265132 Peptidyl spiroheterocyclic, amidino and guanidino compounds; reversible inhibitors of the cysteine protease cathepsin S, K, F, L and B; useful in the treatment of autoimmune and other related diseases |
| 09/04/2007 | US7265131 For therapy of disease-states associated with nuclear receptor activity |
| 09/04/2007 | US7265123 Heterocyclic compounds |
| 09/04/2007 | US7265120 Pyrazine derivatives and pharmaceutical use thereof |
| 09/04/2007 | US7265116 Attention deficit disorders; hyperactivity; post-trauma stress disorders; anxiolytic agents; obsessive compulsive disorders; analgesics; Parkinson's disease |
| 09/04/2007 | US7265114 Antiproliferative agents for smooth muscle cells; antiinflammatory agents for endothelial cells; restenosis, atherosclerosis |
| 09/04/2007 | US7265112 Small molecule modulators of hepatocyte growth factor (scatter factor) activity |
| 09/04/2007 | US7265110 Psychological disorders; antidepressants; anxiolytic agents; analgesics; antiinflammatory agents; central nervous system disorders |
| 09/04/2007 | US7265108 For example, 6-[2-[4-(2-fluorophenoxymethyl)piperidino]ethyl]-1H-pyrazin-2-one; therapeutic or prophylactic agent for diabetic neuralgia, HIV neuralgia, postherpetic neuralgia, nerve system disorders |
| 09/04/2007 | CA2283083C Use of 2,3,4,5-tetrahydro-1h-3-benzazepines for the manufacture of a pharmaceutical composition for the treatment of sleep disorders |
| 09/04/2007 | CA2274063C Substituted pyrimidine compounds and their use |
| 09/04/2007 | CA2258044C Muscarinic antagonists |
| 09/04/2007 | CA2239174C Novel compounds with analgesic effect |
| 08/30/2007 | WO2007098418A1 Compounds having 5-ht6 receptor affinity |
| 08/30/2007 | WO2007098356A1 Congeners of milnacipran as monoamine re-uptake |
| 08/30/2007 | WO2007098214A1 Cinnoline derivatives as phosphodiesterase 10 inhibitors |
| 08/30/2007 | WO2007098169A1 Cinnoline derivatives as phosphodiesterase 10 inhibitors |
| 08/30/2007 | WO2007097937A1 Pyrrolidine derivatives as erk inhibitors |
| 08/30/2007 | WO2007097403A1 Remedy or preventive for digestive ulcer |
| 08/30/2007 | WO2007097197A1 Amide derivative or salt thereof |
| 08/30/2007 | WO2007096751A1 Process for the preparation of atorvastatin calcium |
| 08/30/2007 | WO2007096352A1 5-amino-6-bromo-n-{ [1- (tetrahydr0-2h-pyran-4-ylmethyl) -4-piperidinyl] methyl}-3, 4 -dihydro-2h-chromene-8-carboxamide as 5-ht4 receptor agonist |
| 08/30/2007 | WO2007096072A2 New pyridin-3-amine derivatives |
| 08/30/2007 | WO2007095789A1 Imidazol-5-carboxylic acid derivatives, preparation methods and use therrof |
| 08/30/2007 | WO2007079163A3 Prokineticin 1 receptor antagonists |
| 08/30/2007 | WO2007073303A3 Novel benzimidazole derivatives as vanilloid receptor 1 (vrl) inhibitors |
| 08/30/2007 | WO2007071455B1 Sulfoximine-substituted pyrimidines , their preparation and use as drugs |
| 08/30/2007 | WO2007070556A3 N-(6-membered aromatic ring)-amido anti-viral compounds |
| 08/30/2007 | WO2007042912A3 Heterocyclic compounds as pstat3/il-6 inhibitors |
| 08/30/2007 | WO2007034326A3 Imidazole compounds for the treatment of neurological disorders |
| 08/30/2007 | US20070203338 2-((4,6-dimethoxy)pyrimidin-2-yl-),3-(methoxy-), 3,3-(diphenyl)propionic acid; antihypotensive agents; pulmonary hypertension, mycocardial necrosis; renal failure; brain disorders; antispasmodic agents; antiischemic agents; coagulants; asthma; atherosclerosis; restenosis; Raynaud's syndrome |
| 08/30/2007 | US20070203221 Processes for preparing darifenacin hydrobromide |
| 08/30/2007 | US20070203214 6-Hydroxy-2,2-dimethyl-chroman-4-one; anticancer agents; bioavailability |
| 08/30/2007 | US20070203197 Phosphodiesterase 4 inhibitors |
| 08/30/2007 | US20070203194 Calcium channel modulators comprising 3-thio-4H-1,2,4-triazoles or S-oxides thereof; angina, hypertension, congestive heart failure, myocardial ischemia, arrhythmia, diabetes, urinary incontinence, stroke, pain, brain injury, or neuronal disorders |
| 08/30/2007 | US20070203193 Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist |
| 08/30/2007 | US20070203192 Saturated and unsaturated 3-pyridyl-benzocycloalkylmethyl-amines for use in treating pain, depression and/or anxiety |
| 08/30/2007 | US20070203184 Novel Indolin-2-one Derivatives, Their Preparation and the Pharmaceutical Compositions Comprising Them |
| 08/30/2007 | US20070203179 Azadecalin Glucocorticoid Receptor Modulators |
| 08/30/2007 | US20070203129 2-Pyridone Derivatives As Neutrophil Elastase Inhibitors And Their Use |
| 08/30/2007 | US20070203101 Pyrazolyl-substituted heterocycles and their use as phytosanitary products |